AVGO vs DBD Stock Comparison

AVGO currently leads DBD in this stock comparison, with AIQ scores of 52 vs 50. The clearest difference is quality, while DBD has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 2 points
AVGO
Technology
vs
DBD
Technology
AVGO
Broadcom Inc.
Leads
Price
$347
Day move
-4.76%
AIQ Score
52/100
Best edge
Quality
Sector
Technology
DBD
Diebold Nixdorf, Incorporated
Price
$55.05
Day move
+0.55%
AIQ Score
50/100
Best edge
Value
Sector
Technology

What is the main difference between AVGO and DBD?

AVGO leads the current stock comparison as Broadcom Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs Diebold Nixdorf, Incorporated

Data as of Nov 15, 2026· market close· Technology· Coverage 62/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

AVGO leads

AVGO leads by 2 AIQ points, primarily on Quality and Momentum, but the lead has narrowed from 5 points over 30 sessions.

Fragile: 2 of 5 evidence groups support AVGO, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Weakening
AVGO

Broadcom Inc.

Leads
AIQ Score
52/100
AIQ Edge Score
7/10
DBD

Diebold Nixdorf, Incorporated

AIQ Score
50/100
AIQ Edge Score
4/10

The Algovestiq AIQ Score currently favors AVGO over DBD, 52 versus 50 as of Nov 15, 2026. AVGO's advantage is driven primarily by stronger quality and momentum, while DBD holds the stronger value profile. AVGO also shows the stronger technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor AVGO today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. AVGO lead: Weakening — the AIQ differential moved from 5 to 2 points over 30 sessions.

Compare Broadcom Inc. and Diebold Nixdorf, Incorporated across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+321.9%
DBD
+167.6%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $42,192 · DBD $26,762

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and DBD against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
DBD advantage
  • Value50 vs 79
    DBD +29
  • Quality69 vs 49
    AVGO +20
  • Momentum40 vs 33
    AVGO +7
  • Risk Resilience47 vs 51
    DBD +4

2 of 5 evidence groups favor AVGO. AVGO’s edge is concentrated in quality and momentum; DBD keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AVGO0 AIQ

Largest factor move: Momentum -2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

DBD0 AIQ

Largest factor move: Value -2, not enough on its own to move the overall score.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-17.6%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

AVGO's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and DBD both carry a full feed there.

The central trade-off

AVGO (Broadcom Inc.): the stronger current systematic profile, led by quality and momentum.

DBD (Diebold Nixdorf, Incorporated): the counter-case, on value, risk resilience, valuation.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AVGO

AVGO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

DBD

DBD on the peer-relative Value factor, by 29 points.

Momentum

AVGO

AVGO on the Momentum factor, by 7 points.

Lower downside

DBD

DBD on Risk Resilience, by 4 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureAVGODBDNote
Implied upside to target+48.5%—Level
Target dispersion+48.5%—Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering513Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor AVGO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven52 vs 50
FundamentalsAVGOrevenue growth 33.4% vs 6.8%; EPS growth 40.3% vs -55.6%; gross margin 68.8% vs 25.8%; operating margin 48.4% vs 7.2%
ValuationDBDValue 50 vs 79
TechnicalsAVGOPrice vs 50-day 0.5% vs -12.6%; vs 200-day -5.6% vs -25.9%
Risk ResilienceDBDRisk Resilience 47 vs 51
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and DBD and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVGO.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

AVGO lead: Weakening — the AIQ differential moved from 5 to 2 points over 30 sessions.

May 27AVGO leads above the line · DBD leads belowNov 13
Today
AVGO +2
52 vs 50
7 sessions ago
AVGO +2
50 vs 48
30 sessions ago
AVGO +5
55 vs 50
90 sessions ago
AVGO +3
59 vs 56

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.18x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
DBDConflicted

2 bullish / 3 bearish / 2 neutral, conflicted

Only DBD

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-17.6%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.

AVGO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).

DBDNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.55%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1DBD closes the Quality gap — currently 20 points behind, the largest single contributor to AVGO's edge.
  2. 2DBD's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3AVGO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 2-point move would eliminate AVGO's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGODBD
Revenue growth (YoY)33.4%6.8%
EPS growth (YoY)40.3%-55.6%
Gross margin68.8%25.8%
Operating margin48.4%7.2%
Return on equity (TTM)13.1%0.7%
Debt to equity0.61.2

Performance

AVGO leads 6 of 6 windows
MetricAVGODBD
1 week (5 sessions)18.2%-5.5%
1 month (20 sessions)5.6%-17.6%
3 months (63 sessions)-11.6%-21%
6 months (126 sessions)-18.4%-21%
Year to date0.3%-18.9%
1 year (252 sessions)-2.3%-15.5%

Technicals

AVGO has the stronger structure
MetricAVGODBD
RSI (14)53.234.6
ADX (14)2336.2
Price vs 50-day0.5%-12.6%
Price vs 200-day-5.6%-25.9%
Volatility (1M, annualized)70%61.2%

Risk

DBD is the more resilient
MetricAVGODBD
Beta2.211.01
Sharpe ratio0.21-0.31
Sortino ratio0.29-0.38
Max drawdown-39.5%-39.7%
Current drawdown-27.9%-39.3%
Annualized volatility48.6%40.7%
Value at risk (95%)-4.6%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or DBD?

On the Algovestiq AIQ Score, AVGO is the stronger of the two as of Nov 15, 2026, scoring 52 against DBD's 50. The edge comes from quality and momentum. DBD is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or DBD the better buy right now?

AVGO carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.

Why does the AIQ Score favor AVGO over DBD?

The composite weights Quality, Value, Momentum and Risk Resilience. DBD leads Value by 29 points; AVGO leads Quality by 20 points; AVGO leads Momentum by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or DBD?

Analyst price targets imply +48.5% upside for AVGO and not covered for DBD. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or DBD?

DBD is the better-valued of the two on the peer-relative Value factor. DBD on the peer-relative Value factor, by 29 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or DBD?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or DBD?

AVGO on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or DBD?

DBD is the more resilient of the two, so the other name carries the higher downside risk. DBD on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than DBD?

AVGO leads on the comparable margin measures — gross margin 68.8% vs 25.8%; operating margin 48.4% vs 7.2%; ttm roe 13.1% vs 0.7%.

Is AVGO's lead over DBD getting stronger or weaker?

AVGO lead: Weakening — the AIQ differential moved from 5 to 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the AVGO vs DBD verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DBD closes the Quality gap — currently 20 points behind, the largest single contributor to AVGO's edge; DBD's Death Cross Active resolves — a bearish trend rule currently active against it; AVGO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 2-point move would eliminate AVGO's advantage entirely.

What do the current signals say about AVGO and DBD?

AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. DBD: 2 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On DBD it is Death Cross Active (bearish, long horizon).

Compare AVGO and DBD with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.